• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唾液腺良性和恶性肿瘤中CD44s、CD44v6、CXCR2、CXCL1和IL-1β的评估

Evaluation of CD44s, CD44v6, CXCR2, CXCL1, and IL-1β in Benign and Malignant Tumors of Salivary Glands.

作者信息

Laohavisudhi Fonthip, Chunchai Titikorn, Ketchaikosol Natnicha, Thosaporn Wacharaporn, Chattipakorn Nipon, Chattipakorn Siriporn C

机构信息

Department of Oral Biology and Oral Diagnostic Sciences, Faculty of Dentistry, Chiang Mai University, Chiang Mai 50200, Thailand.

Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.

出版信息

Diagnostics (Basel). 2022 May 20;12(5):1275. doi: 10.3390/diagnostics12051275.

DOI:10.3390/diagnostics12051275
PMID:35626430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9141664/
Abstract

BACKGROUND

Several studies have reported an association between high expression of CD44 in different types of cancer. However, no study has reported a link among CD44 expression, other biomarkers, and the aggressiveness of salivary gland tumors.

METHODS

A total of 38 specimens were obtained from non-tumorous salivary glands, benign and malignant tumors in salivary glands. Immunohistochemical analyses of CD44s, CD44v6, IL-1β, CXCL1, and CXCR2 were performed, and the area of positive cells was assessed.

RESULTS

We found that both CD44s and CXCR2 expression were increased in the benign and malignant groups. CD44v6 was also increased in both groups, but it had the highest level in the malignant group. IL-1β was the only biomarker that increased significantly in the malignant group in comparison to the other two groups.

CONCLUSIONS

CD44s, CD44v6, CXCR2, and IL-1β expressions were found to be higher in salivary gland tumors. However, IL-1β alone may play a crucial role in the aggressiveness of salivary gland tumors as this cytokine was expressed only in the malignant group with high expression associated with high-grade malignancy.

摘要

背景

多项研究报告了不同类型癌症中CD44高表达之间的关联。然而,尚无研究报道CD44表达、其他生物标志物与涎腺肿瘤侵袭性之间的联系。

方法

从非肿瘤性涎腺、涎腺良性和恶性肿瘤中总共获取了38个标本。对CD44s、CD44v6、IL-1β、CXCL1和CXCR2进行免疫组织化学分析,并评估阳性细胞面积。

结果

我们发现,CD44s和CXCR2表达在良性和恶性组中均增加。CD44v6在两组中也增加,但在恶性组中水平最高。与其他两组相比,IL-1β是唯一在恶性组中显著增加的生物标志物。

结论

发现CD44s、CD44v6、CXCR2和IL-1β在涎腺肿瘤中表达较高。然而,单独的IL-1β可能在涎腺肿瘤的侵袭性中起关键作用,因为这种细胞因子仅在恶性组中表达,且高表达与高级别恶性肿瘤相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f78/9141664/5ee9c5299bd9/diagnostics-12-01275-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f78/9141664/9194fe1f1859/diagnostics-12-01275-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f78/9141664/0a41550db3a7/diagnostics-12-01275-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f78/9141664/2135c4bbcf5c/diagnostics-12-01275-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f78/9141664/f572fde22d12/diagnostics-12-01275-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f78/9141664/5ee9c5299bd9/diagnostics-12-01275-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f78/9141664/9194fe1f1859/diagnostics-12-01275-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f78/9141664/0a41550db3a7/diagnostics-12-01275-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f78/9141664/2135c4bbcf5c/diagnostics-12-01275-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f78/9141664/f572fde22d12/diagnostics-12-01275-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f78/9141664/5ee9c5299bd9/diagnostics-12-01275-g005.jpg

相似文献

1
Evaluation of CD44s, CD44v6, CXCR2, CXCL1, and IL-1β in Benign and Malignant Tumors of Salivary Glands.唾液腺良性和恶性肿瘤中CD44s、CD44v6、CXCR2、CXCL1和IL-1β的评估
Diagnostics (Basel). 2022 May 20;12(5):1275. doi: 10.3390/diagnostics12051275.
2
[The expression of CD44s and CD44v6 in human salivary adenoid cystic carcinoma ].[CD44s和CD44v6在人涎腺腺样囊性癌中的表达]
Shanghai Kou Qiang Yi Xue. 1999 Sep;8(3):159-62.
3
The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.CD44 亚型在接受根治性前列腺切除术的前列腺癌患者中的预后价值。
Clin Cancer Res. 1997 May;3(5):805-15.
4
CD44s and CD44v6 expression in head and neck epithelia.CD44s和CD44v6在头颈部上皮中的表达。
PLoS One. 2008;3(10):e3360. doi: 10.1371/journal.pone.0003360. Epub 2008 Oct 9.
5
Expression of CD44s and CD44v6 in lung cancer and their correlation with prognostic factors.CD44s 和 CD44v6 在肺癌中的表达及其与预后因素的相关性。
Int J Biol Markers. 2011 Jan-Mar;26(1):50-7. doi: 10.5301/jbm.2011.6291.
6
CD44s and CD44v6 in diagnosis and prognosis of human bladder cancer.CD44s和CD44v6在人类膀胱癌诊断及预后中的应用
Ultrastruct Pathol. 2012 May;36(3):145-52. doi: 10.3109/01913123.2011.651522.
7
Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.透明质酸及其受体CD44s和CD44v6在正常、增生和肿瘤性子宫内膜中的表达。
Ann Diagn Pathol. 2005 Dec;9(6):312-8. doi: 10.1016/j.anndiagpath.2005.07.004.
8
Immunohistochemical analysis of CD44s and CD44v6 in endometriosis and adenomyosis : comparison with normal, hyperplastic, and malignant endometrium.子宫内膜异位症和子宫腺肌病中CD44s和CD44v6的免疫组织化学分析:与正常、增生性和恶性子宫内膜的比较
J Korean Med Sci. 2001 Jun;16(3):317-22. doi: 10.3346/jkms.2001.16.3.317.
9
Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer.E-钙黏蛋白、CD44s和CD44v6在头颈癌中的表达及其与预后的关系。
Auris Nasus Larynx. 2004 Mar;31(1):35-41. doi: 10.1016/j.anl.2003.09.005.
10
Diagnostic utility of CD44 standard, CD44v6, and CD44v3-10 expression in adenocarcinomas presenting in serous fluids.CD44标准型、CD44v6及CD44v3-10在浆液性积液腺癌中的诊断价值
Appl Immunohistochem Mol Morphol. 2007 Dec;15(4):446-50. doi: 10.1097/01.pai.0000213154.49063.22.

引用本文的文献

1
The Evaluation of Blood Prooxidant-Antioxidant Balance Indicators and Cortisol Pre- and Post-Surgery in Patients with Benign Parotid Gland Tumors: A Preliminary Study.腮腺良性肿瘤患者手术前后血液促氧化剂-抗氧化剂平衡指标及皮质醇的评估:一项初步研究
J Clin Med. 2025 Aug 1;14(15):5425. doi: 10.3390/jcm14155425.
2
The Impact of Inflammation on the Etiopathogenesis of Benign Salivary Gland Tumors: A Scoping Review.炎症对涎腺良性肿瘤病因发病机制的影响:一项范围综述
Int J Mol Sci. 2024 Nov 22;25(23):12558. doi: 10.3390/ijms252312558.

本文引用的文献

1
Mediators of extracellular matrix degradation and inflammation: A new team of possible biomarkers for oral squamous cell carcinoma stage.细胞外基质降解与炎症的介质:一组用于口腔鳞状细胞癌分期的新型潜在生物标志物
Exp Ther Med. 2021 Aug;22(2):877. doi: 10.3892/etm.2021.10309. Epub 2021 Jun 15.
2
Immunohistochemical expression of OCT4 and CD44 in major and minor salivary gland neoplasms.OCT4 和 CD44 在大、小唾液腺肿瘤中的免疫组织化学表达。
Braz Oral Res. 2021 Jun 16;35:e073. doi: 10.1590/1807-3107bor-2021.vol35.0073. eCollection 2021.
3
Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma.
CXC趋化因子家族在头颈部鳞状细胞癌中的预后及治疗价值分析
Front Oncol. 2021 Jan 8;10:570736. doi: 10.3389/fonc.2020.570736. eCollection 2020.
4
NF-κB-mediated lncRNA AC007271.3 promotes carcinogenesis of oral squamous cell carcinoma by regulating miR-125b-2-3p/Slug.NF-κB 介导的长链非编码 RNA AC007271.3 通过调控 miR-125b-2-3p/Slug 促进口腔鳞状细胞癌的发生。
Cell Death Dis. 2020 Dec 12;11(12):1055. doi: 10.1038/s41419-020-03257-4.
5
High CXCR2 expression predicts poor prognosis in adult patients with acute myeloid leukemia.CXCR2高表达预示成年急性髓系白血病患者预后不良。
Ther Adv Hematol. 2020 Sep 14;11:2040620720958586. doi: 10.1177/2040620720958586. eCollection 2020.
6
Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma.CXCL1 的升高通过诱导胶质母细胞瘤中的间充质转化而预示不良预后和放射抵抗。
CNS Neurosci Ther. 2020 Apr;26(4):475-485. doi: 10.1111/cns.13297.
7
Breast Cancer Cell-Derived Soluble CD44 Promotes Tumor Progression by Triggering Macrophage IL1β Production.乳腺癌细胞衍生的可溶性 CD44 通过触发巨噬细胞 IL1β 产生促进肿瘤进展。
Cancer Res. 2020 Mar 15;80(6):1342-1356. doi: 10.1158/0008-5472.CAN-19-2288. Epub 2020 Jan 22.
8
Tumor Cell-Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer.肿瘤细胞衍生的白细胞介素 1β促进胰腺癌中的纤维母细胞增生和免疫抑制。
Cancer Res. 2020 Mar 1;80(5):1088-1101. doi: 10.1158/0008-5472.CAN-19-2080. Epub 2020 Jan 8.
9
Semi-quantitative Determination of Protein Expression using Immunohistochemistry Staining and Analysis: An Integrated Protocol.使用免疫组织化学染色和分析进行蛋白质表达的半定量测定:综合方案
Bio Protoc. 2019 Dec 20;9(24). doi: 10.21769/BioProtoc.3465.
10
Elevated CD44 expression predicts poor prognosis in patients with low-grade glioma.CD44表达升高预示低级别胶质瘤患者预后不良。
Oncol Lett. 2019 Oct;18(4):3698-3704. doi: 10.3892/ol.2019.10728. Epub 2019 Aug 7.